In fact, kaempferol is capable of inhibiting numerous cancer cells by inducing cell death, cell cycle inhibition at the G2/M-phase, the reduced expression of signal-transduction pathways, phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), and the expression of epithelial–mesenchymal transition (EMT)-related markers (N-cadherin, E-cadherin, Snail, and Slug) [112,113]. Here, AKT1 is linked to cancer.